METHYLPHENIDATE

Clinical Indication

Attention deficit hyperactivity disorder (ADHD)- prescribe CR formulation by brand name only

Comments

For information about products please see relevant Shared Care and Net Formulary
Adults: Full SCA
Children & adolescents: Full SCA

Note: Medikinet XL® – No new initiations from September 2026. Existing patients prescribed Medikinet XL should be switched to Ambinet XL at an appropriate clinical review.

Date of classification

January 2009

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.